The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced funding for a new project aimed at improving management of side effects caused by poly ...

Protein Blocking Bone Development Could Hold Clues for Future Osteoporosis Treatment Oct. 11, 2024 — Scientists have identified a protein that blocks the activity of bone-forming cells ...

This drug approval followed the publication of the EMBARK trial, a randomized phase III trial of biochemically recurrent patients who had high-risk disease, defined by a PSA doubling time (PSADT) ≤9 ...

This page includes links to articles highlighting the top genitourinary cancer research published on Cancer Therapy Advisor in 2024.

A Cork University Hospital trial of physical therapy for men battling metastatic cancers of the urinary tract and reproductive systems – and named with a nod to a hurling legend – is already ...

Combining intermittent fasting with localised Wnt3a treatments can rejuvenate bone repair in older mice, offering hope for reversing age-related tissue decline.

A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.

At 8 years old, Raine Talley spent a lot of time in and out of children’s hospitals in Philadelphia and Delaware to get ...

and a bone-protecting agent may be a new treatment option for mCRPC patients with bone metastases, according to Silke Gillessen, MD. Radium-223 provided a 3-month improvement in radiographic ...

7Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas. 9Winthrop P. Rockefeller Cancer Institute ...

Your body's blood supply — red and white blood cells alike — is produced in bone marrow, a spongy tissue found in your bones, ensuring your body remains oxygenated and protected from disease. Because ...